Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matti Waterman

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Gut|April 6, 2018
Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBDRenaud Gaujoux, Elina Starosvetsky, Naama Maimon, et al.
Inflammatory Bowel Diseases|August 31, 2016
Genetic Predictors of Benign Course of Ulcerative Colitis-A North American Inflammatory Bowel Disease Genetics Consortium StudyUri Kopylov, Gabrielle Boucher, Matti Waterman, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 3, 2018
Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease-The Israeli real world experienceUri Kopylov, Irit Avni-Biron, Yulia Ron, et al.
Inflammatory Bowel Diseases|February 9, 2017
Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World ExperienceUri Kopylov, Yulia Ron, Irit Avni-Biron, et al.
United European Gastroenterology Journal|March 28, 2020
Safety and effectiveness of ustekinumab for induction of remission in patients with Crohn's disease: A multicenter Israeli studyAriella Bar-Gil Shitrit, Ami Ben-Ya'acov, Matan Siterman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 7, 2020
Early Indolent Course of Crohn's Disease in Newly Diagnosed Patients Is Not Rare and Possibly PredictableHenit Yanai, Idan Goren, Lihi Godny, et al.
Gastroenterology|January 27, 2015
Accuracy of capsule colonoscopy in detecting colorectal polyps in a screening populationDouglas K Rex, Samuel N Adler, James Aisenberg, et al.
Inflammatory Bowel Diseases|June 8, 2017
Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective StudyUri Kopylov, Konstantinos Papamichael, Konstantinos Katsanos, et al.
Plos Genetics|March 14, 2012
A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility lociEimear E Kenny, Itsik Pe'er, Amir Karban, et al.
Vaccines|March 26, 2022
COVID-19 in Patients with Inflammatory Bowel Disease: The Israeli ExperienceLev Lichtenstein, Benjamin Koslowsky, Ami Ben Ya'acov, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Gut|April 6, 2018
Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBDRenaud Gaujoux, Elina Starosvetsky, Naama Maimon, et al.
Inflammatory Bowel Diseases|August 31, 2016
Genetic Predictors of Benign Course of Ulcerative Colitis-A North American Inflammatory Bowel Disease Genetics Consortium StudyUri Kopylov, Gabrielle Boucher, Matti Waterman, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 3, 2018
Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease-The Israeli real world experienceUri Kopylov, Irit Avni-Biron, Yulia Ron, et al.
Inflammatory Bowel Diseases|February 9, 2017
Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World ExperienceUri Kopylov, Yulia Ron, Irit Avni-Biron, et al.
United European Gastroenterology Journal|March 28, 2020
Safety and effectiveness of ustekinumab for induction of remission in patients with Crohn's disease: A multicenter Israeli studyAriella Bar-Gil Shitrit, Ami Ben-Ya'acov, Matan Siterman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 7, 2020
Early Indolent Course of Crohn's Disease in Newly Diagnosed Patients Is Not Rare and Possibly PredictableHenit Yanai, Idan Goren, Lihi Godny, et al.
Gastroenterology|January 27, 2015
Accuracy of capsule colonoscopy in detecting colorectal polyps in a screening populationDouglas K Rex, Samuel N Adler, James Aisenberg, et al.
Inflammatory Bowel Diseases|June 8, 2017
Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective StudyUri Kopylov, Konstantinos Papamichael, Konstantinos Katsanos, et al.
Plos Genetics|March 14, 2012
A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility lociEimear E Kenny, Itsik Pe'er, Amir Karban, et al.
Vaccines|March 26, 2022
COVID-19 in Patients with Inflammatory Bowel Disease: The Israeli ExperienceLev Lichtenstein, Benjamin Koslowsky, Ami Ben Ya'acov, et al.
Pageof 5